Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Treatment of hypertension in African Americans and Latinos: the effect of JNC VI on urban prescribing practices.

Henderson SO, Bretsky P, DeQuattro V, Henderson BE.

J Clin Hypertens (Greenwich). 2003 Mar-Apr;5(2):107-12.

2.

Sympatholytic therapy in primary hypertension: a user friendly role for the future.

DeQuattro V, Li D.

J Hum Hypertens. 2002 Mar;16 Suppl 1:S118-23. Review.

3.

The sympathetic nervous system: the muse of primary hypertension.

DeQuattro V, Feng M.

J Hum Hypertens. 2002 Mar;16 Suppl 1:S64-9. Review.

4.

One-year study of felodipine or placebo for stage 1 isolated systolic hypertension.

Black HR, Elliott WJ, Weber MA, Frishman WH, Strom JA, Liebson PR, Hwang CT, Ruff DA, Montoro R, DeQuattro V, Zhang D, Schleman MM, Klibaner MI.

Hypertension. 2001 Nov;38(5):1118-23.

PMID:
11711508
5.

Elevated blood pressure in subjects with lipodystrophy.

Sattler FR, Qian D, Louie S, Johnson D, Briggs W, DeQuattro V, Dube MP.

AIDS. 2001 Oct 19;15(15):2001-10.

PMID:
11600829
6.

Norepinephrine producing renal cell carcinoma.

Koh CJ, Bochner BH, Stein JP, Fedenko AN, Dequattro V, Skinner DG.

J Urol. 2001 Aug;166(2):603. No abstract available.

PMID:
11458078
7.

Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Grimm RH Jr, Margolis KL, Papademetriou V V, Cushman WC, Ford CE, Bettencourt J, Alderman MH, Basile JN, Black HR, DeQuattro V V, Eckfeldt J, Hawkins CM, Perry HM Jr, Proschan M.

Hypertension. 2001 Jan;37(1):19-27.

PMID:
11208751
8.

A Therapeutic Commentary.

DeQuattro V V, Li D.

J Cardiovasc Pharmacol Ther. 1997 Oct;2(4):331-335.

PMID:
10684474
9.

Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement.

Palmieri V, Dahlöf B, DeQuattro V, Sharpe N, Bella JN, de Simone G, Paranicas M, Fishman D, Devereux RB.

J Am Coll Cardiol. 1999 Nov 1;34(5):1625-32.

10.

Relations of diastolic left ventricular filling to systolic chamber and myocardial contractility in hypertensive patients with left ventricular hypertrophy (The PRESERVE Study).

Palmieri V, Bella JN, DeQuattro V, Roman MJ, Hahn RT, Dahlof B, Sharpe N, Lau CP, Chen WC, Paran E, de Simone G, Devereux RB.

Am J Cardiol. 1999 Sep 1;84(5):558-62.

PMID:
10482155
11.
12.

Effective dose range of candesartan cilexetil for systemic hypertension. Candesartan Cilexetil Study Investigators.

Bell TP, DeQuattro V, Lasseter KC, Ruff D, Hardison JD, Cushing D, Kezer AE, Michelson EL.

Am J Cardiol. 1999 Jan 15;83(2):272-5, A6.

PMID:
10073836
13.

Low-dose combination therapy as first-line hypertension treatment for blacks and nonblacks.

Prisant LM, Neutel JM, Ferdinand K, Papademetriou V, DeQuattro V, Hall WD, Weir MR.

J Natl Med Assoc. 1999 Jan;91(1):40-8.

14.

Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.

Bakris GL, Weir MR, DeQuattro V, McMahon FG.

Kidney Int. 1998 Oct;54(4):1283-9.

15.

Toward improved antihypertensive therapy with calcium channel blockers.

DeQuattro V.

Ethn Dis. 1998 Winter;8(1):103-10. Review.

PMID:
9595254
16.
17.

Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris.

Alpert JS, Kobrin I, DeQuattro V, Friedman R, Shepherd A, Fenster PE, Thadani U.

Am J Cardiol. 1997 Apr 15;79(8):1025-30.

PMID:
9114758
18.
20.

The impact of ethnicity on response to antihypertensive therapy.

Jamerson K, DeQuattro V.

Am J Med. 1996 Sep 30;101(3A):22S-32S. Review.

PMID:
8876472
21.

Neural mechanisms in primary hypertension. Efficacy of alpha-blockade with doxazosin during stress.

Lee D, Lu ZW, DeQuattro V.

Am J Hypertens. 1996 Jan;9(1):47-53.

PMID:
8834706
22.

Individualization of therapy for hypertension in the 1990's: the role of calcium antagonists.

DeQuattro V.

Clin Exp Hypertens. 1994 Nov;16(6):853-64. Review.

PMID:
7858564
23.

A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide.

Frishman WH, Bryzinski BS, Coulson LR, DeQuattro VL, Vlachakis ND, Mroczek WJ, Dukart G, Goldberg JD, Alemayehu D, Koury K.

Arch Intern Med. 1994 Jul 11;154(13):1461-8. Erratum in: Arch Intern Med 1995 Apr 10;155(7):709.

PMID:
8018001
24.
25.

The perioperative management of pheochromocytoma in children.

Turner MC, Lieberman E, DeQuattro V.

Clin Pediatr (Phila). 1992 Oct;31(10):583-9.

PMID:
1395364
26.

Silent myocardial ischemia in patients with essential hypertension.

Yurenev AP, DeQuattro V, Dubov PB, Ostroumov EN, Nikulin IA, Konyaeva EB, Balyakina EV, Atachanov SE, Kosenko AI, Popov EG, et al.

Am J Hypertens. 1992 Jun;5(6 Pt 2):169S-174S.

PMID:
1632937
27.
28.

Blood pressure reactivity and sympathetic hyperactivity. Predictors of hypertension.

DeQuattro V, Lee DD.

Am J Hypertens. 1991 Nov;4(11):624S-628S. Review.

PMID:
1789945
29.

Relaxation, reduction in angry articulated thoughts, and improvements in borderline hypertension and heart rate.

Davison GC, Williams ME, Nezami E, Bice TL, DeQuattro VL.

J Behav Med. 1991 Oct;14(5):453-68.

PMID:
1744909
30.
31.

Effect of beta-blockade on low heart rate-related ischemia during mental stress.

Bairey CN, Krantz DS, DeQuattro V, Berman DS, Rozanski A.

J Am Coll Cardiol. 1991 May;17(6):1388-95.

32.

Comparison of labetalol versus enalapril as monotherapy in elderly patients with hypertension: results of 24-hour ambulatory blood pressure monitoring.

Applegate WB, Borhani N, DeQuattro V, Kaihlanen PM, Oishi S, Due DL, Sirgo MA.

Am J Med. 1991 Feb;90(2):198-205.

PMID:
1996588
33.
34.

Pathogenesis of cardiac neuro-myopathy in Chagas' disease and the role of the autonomic nervous system.

Iosa D, Dequattro V, Lee DD, Elkayam U, Caeiro T, Palmero H.

J Auton Nerv Syst. 1990 Jul;30 Suppl:S83-7. No abstract available.

PMID:
2212497
35.

Evaluation of the clinical pharmacology of nilvadipine in patients with mild to moderate essential hypertension.

Weir MR, Vlachkis ND, DeQuattro V, Douglas J, Svetkey LP, Singh S, Wiedl SC, Chen CF, Woodward DL, Saunders E.

J Clin Pharmacol. 1990 May;30(5):425-37.

PMID:
2189903
36.

Generalized anxiety disorder: some biochemical aspects.

Munjack DJ, Baltazar PL, DeQuattro V, Sobin P, Palmer R, Zulueta A, Crocker B, Usigli R, Buckwalter G, Leonard M.

Psychiatry Res. 1990 Apr;32(1):35-43.

PMID:
2349311
37.

JNC-IV and the evolution of stepped care to individualized treatment of hypertension.

DeQuattro V.

J Cardiovasc Pharmacol. 1990;15 Suppl 3:S16-21.

PMID:
1691413
38.

Primary hypertension, neural tone, and behavior. Role in pressor responses to stress.

DeQuattro V.

Am J Hypertens. 1989 Dec;2(12 Pt 2):345S-352S. Review.

PMID:
2574587
39.

Plasma norepinephrine in Chagas' cardioneuromyopathy: a marker of progressive dysautonomia.

Iosa D, DeQuattro V, Lee DD, Elkayam U, Palmero H.

Am Heart J. 1989 Apr;117(4):882-7.

PMID:
2494874
40.
41.
42.

Effects of antihypertensive agents on circadian blood pressure and heart rate patterns. Review.

Sirgo MA, Mills RJ, DeQuattro V.

Arch Intern Med. 1988 Dec;148(12):2547-52. Review.

PMID:
3058070
43.

Effects of celiprolol on plasma renin, aldosterone, norepinephrine and epinephrine in primary hypertension.

Kimura S, DeQuattro V, Hernandez PH, Lee DD.

Am J Cardiol. 1988 Oct 1;62(10 Pt 1):751-4.

PMID:
2971310
44.
45.

Labetalol blunts morning pressor surge in systolic hypertension.

DeQuattro V, Lee DD, Allen J, Sirgo M, Plachetka J.

Hypertension. 1988 Feb;11(2 Pt 2):I198-201.

PMID:
3278976
46.

Noradrenergic hyperactivity in primary hypertension; central and peripheral markers of both behavioral pathogenesis and efficacy of sympatholytic and relaxation therapy.

Lee DD, DeQuattro V, Davison GC, Kimura S, Barndt R, Sullivan P.

Clin Exp Hypertens A. 1988;10 Suppl 1:225-34.

PMID:
3072125
47.

Primary hypertension: left ventricular mass and function, sympathetic nervous system activity, and therapy.

DeQuattro V, Lee DD, Shkhvatsabaya IK, Yurenev AP, Salenko BB, Allen J, Azen S, Barndt R, Foti A, Davison G.

Health Psychol. 1988;7 Suppl:165-73.

PMID:
2977327
48.

Liquid-chromatographic measurement of catecholamines and metabolites in plasma and urine.

Foti A, Kimura S, DeQuattro V, Lee D.

Clin Chem. 1987 Dec;33(12):2209-13.

49.

Efficacy of bucindolol in systemic hypertension.

Kimura S, DeQuattro V, Edmiston WA, Loo R, Thien S, Rigonan K, Deitchman D, Foti A.

Am J Cardiol. 1987 Nov 1;60(13):1083-6.

PMID:
2890292
50.

Neurohumoral mechanisms and left ventricular hypertrophy: effects of hygienic therapy.

Lee DD, DeQuattro V, Cox T, Pyter L, Foti A, Allen J, Barndt R, Azen S, Davison G.

J Hum Hypertens. 1987 Sep;1(2):147-51.

PMID:
3333525

Supplemental Content

Loading ...
Support Center